Bugarin-Estrada, E., Monge, J., Pearse, R., Niesvizky, R., & Mejia Saldarriaga, M. (2024). Evaluating the Kinetics of Absolute Lymphocyte Counts Following Bispecific T-Cell Engager Therapy to Predict Clinical Outcomes in Relapsed/Refractory Multiple Myeloma. Blood, 144(Supplement 1), 1942. https://doi.org/10.1182/blood-2024-209148
Chicago Style (17th ed.) CitationBugarin-Estrada, Emmanuel, Jorge Monge, Roger Pearse, Ruben Niesvizky, and Mateo Mejia Saldarriaga. "Evaluating the Kinetics of Absolute Lymphocyte Counts Following Bispecific T-Cell Engager Therapy to Predict Clinical Outcomes in Relapsed/Refractory Multiple Myeloma." Blood 144, no. Supplement 1 (2024): 1942. https://doi.org/10.1182/blood-2024-209148.
MLA (9th ed.) CitationBugarin-Estrada, Emmanuel, et al. "Evaluating the Kinetics of Absolute Lymphocyte Counts Following Bispecific T-Cell Engager Therapy to Predict Clinical Outcomes in Relapsed/Refractory Multiple Myeloma." Blood, vol. 144, no. Supplement 1, 2024, p. 1942, https://doi.org/10.1182/blood-2024-209148.